Skip to main content
. 2026 Jan 21;48(1):113. doi: 10.3390/cimb48010113
miRNA Micro RNA
CA-125 Cancer Antigen 125
IL-33 Interleukin-33
ST2 Suppression of Tumorigenicity 2
sST2 Soluble ST2
EOC Epithelial over cancer
ROC Receiver Operating Characteristic
AUC Area under curve